Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis

scientific article

Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1093/SCHBUL/SBS136
P932PMC publication ID3885287
P698PubMed publication ID23180756
P5875ResearchGate publication ID233770701

P50authorPaolo Fusar-PoliQ21094931
Philip McGuireQ37834611
Alison R. YungQ37835108
Lucia ValmaggiaQ42823642
Barnaby NelsonQ62583760
P2860cites workBias in meta-analysis detected by a simple, graphical testQ24685585
At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical riskQ27002449
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ27860868
Klaus Conrad (1905-1961): delusional mood, psychosis, and beginning schizophreniaQ33566183
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.Q33775024
Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis.Q33950926
Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorderQ34010659
Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disordersQ34124435
Cognitive functioning in prodromal psychosis: a meta-analysisQ34278910
Global assessment of functioning. A modified scaleQ34302424
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental StatesQ34475129
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North AmericaQ34586836
Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adultsQ34604368
Should attenuated psychosis syndrome be included in DSM-5?Q34635905
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical riskQ34636460
At clinical high risk for psychosis: outcome for nonconvertersQ35148454
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk researchQ35768192
Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosisQ35768219
Introduction: The extended psychosis phenotype--relationship with schizophrenia and with ultrahigh risk status for psychosis.Q35768254
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.Q35873850
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosisQ35903811
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studiesQ36386404
Risk factors for psychosis: impaired social and role functioningQ36386414
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorderQ37208950
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.Q37224904
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal StudyQ37310198
Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders.Q37781124
The psychosis high-risk state: a comprehensive state-of-the-art reviewQ38061036
Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in lifeQ44974332
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosisQ46762892
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosisQ48394255
Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countriesQ48705979
Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.Q50803831
The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorderQ51695488
Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?Q51828879
Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis.Q51862013
Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia.Q51873130
PACE: a specialised service for young people at risk of psychotic disorders.Q51896853
Association between psychotic experiences and depression in a clinical sample over 6 months.Q51907815
Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls.Q51928424
Is our concept of schizophrenia influenced by Berkson's bias?Q51938411
Reduced subjective quality of life in persons at risk for psychosis.Q53159612
Lost in transition: setting the psychosis threshold in prodromal researchQ53961984
Limitations of the Application of Fourfold Table Analysis to Hospital DataQ56503537
Disability in people clinically at high risk of psychosisQ60445896
The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?Q60545829
Depression, negative symptoms, social stagnation and social decline in the early course of schizophreniaQ78236834
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectanxietyQ154430
psychosisQ170082
P304page(s)120-131
P577publication date2012-11-22
P1433published inSchizophrenia BulletinQ4049133
P1476titleComorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis
P478volume40

Reverse relations

cites work (P2860)
Q96034543"I don't think I took her fears seriously." Exploring the experiences of family members of individuals at-risk of developing psychosis over 12-months
Q90752929'At risk mental state' clinics for psychosis - an idea whose time has come - and gone!
Q52317815'False-positive' self-reported psychotic experiences in the general population: an investigation of outcome, predictive factors and clinical relevance.
Q92862585A Mentalization-Informed Staging Approach to Clinical High Risk for Psychosis
Q33670654A critique of the "ultra-high risk" and "transition" paradigm
Q47668934A longitudinal mediation analysis of the effect of negative-self-schemas on positive symptoms via negative affect.
Q38660807A qualitative phenomenological analysis of the subjective experience and understanding of the at risk mental state
Q37540848A randomized trial of family focused therapy with populations at clinical high risk for psychosis: effects on interactional behavior
Q38819011A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis
Q40084185A systematic review and meta-analysis of mental health service use in people who report psychotic experiences.
Q96640306Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis
Q47562372Addiction Vulnerability: Exploring Relationships Between Cigarette Smoking, Substance Misuse and Early Psychosis.
Q89667017Advances in clinical staging, early intervention, and the prevention of psychosis
Q26741515Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment
Q48043070All that glitters is not gold: prevalence and relevance of psychotic-like experiences in clinical sample of children and adolescents aged 8-17 years old.
Q30381309Alterations in the hippocampus and thalamus in individuals at high risk for psychosis.
Q45839278Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis
Q43073835An Overview of Recent Findings on Social Anxiety Disorder in Adolescents and Young Adults at Clinical High Risk for Psychosis.
Q57519639Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study
Q38611406Anxiety in Patients with Schizophrenia: Epidemiology and Management
Q37017300Anxiety in youth at clinical high risk for psychosis
Q48068643Applicability of the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) for identifying attenuated psychosis syndrome in a college population
Q38258292Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis.
Q39153105Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk.
Q37622280Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.
Q60639098Association of Primary Care Consultation Patterns With Early Signs and Symptoms of Psychosis
Q93369149Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
Q36118724At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction
Q38114968Attenuated psychosis syndrome in DSM-5.
Q46228189Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort
Q44627179Behavioural activation therapy for adolescents 'at risk' for psychosis?
Q38826685Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis
Q91669884Borderline Personality Pathology in an At Risk Mental State Sample
Q48089122Borderline personality pathology in young people at ultra high risk of developing a psychotic disorder
Q90361881Breaking the web: life beyond the at-risk mental state for psychosis
Q47604884Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk
Q50041332Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders.
Q47316102Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis
Q47836760Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators
Q26770197Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis
Q37710469Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis
Q33762519Characterization of psychotic experiences in adolescence using the specific psychotic experiences questionnaire: findings from a study of 5000 16-year-old twins.
Q90926751Childhood adversities in people at ultra-high risk (UHR) for psychosis: a systematic review and meta-analysis
Q92699971Childhood temperament is associated with distress, anxiety and reduced quality of life in schizophrenia spectrum disorders
Q90128803Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project
Q47621148Clinical high risk for psychosis in children and adolescents: a systematic review
Q48088952Clinical high risk for psychosis: gender differences in symptoms and social functioning
Q58613991Combined cognitive, psychomotor and electrophysiological biomarkers in major depressive disorder
Q30380217Common and divergent psychobiological mechanisms underlying maternal behaviors in non-human and human mammals
Q47721523Common mental disorder including psychotic experiences: Trailblazing a new recovery pathway within the Improving Access to Psychological Therapies programme in England
Q45159123Comorbid Mental Disorders and 6-Month Symptomatic and Functioning Outcomes in Chinese University Students at Clinical High Risk for Psychosis
Q27015872Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment
Q92105678Comorbid Personality Disorders in Individuals With an At-Risk Mental State for Psychosis: A Meta-Analytic Review
Q46819894Comorbid diagnoses for youth at clinical high risk of psychosis
Q42052463Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
Q58576623Coproducing healthcare service improvement for people with common mental health disorders including psychotic experiences: a study protocol of a multiperspective qualitative study
Q50420782Core beliefs in healthy youth and youth at ultra high-risk for psychosis: Dimensionality and links to depression, anxiety, and attenuated psychotic symptoms
Q30993265Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy
Q47837277Course of clinical high-risk states for psychosis beyond conversion
Q46365588Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review.
Q34123531Current status specifiers for patients at clinical high risk for psychosis
Q38898192Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue?
Q47841045Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort.
Q41068640Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project
Q35096522Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers
Q47862021Developing and Validating a Computerized Adaptive Test to Measure Broad and Specific Factors of Internalizing in a Community Sample
Q38868964Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.
Q38980241Development of self-inflicted injury: Comorbidities and continuities with borderline and antisocial personality traits
Q92132960Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia
Q26795451Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis
Q40051964Do fewer males present to clinical high-risk services for psychosis relative to first-episode services?
Q47417241Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome
Q64261741Early Somatosensory Processing Over Time in Individuals at Risk to Develop Psychosis
Q48527862Early referral and comorbidity as possible causes of the declining transition rate in subjects at clinical high risk for psychosis
Q30397626Effect of acute swim stress on plasma corticosterone and brain monoamine levels in bidirectionally selected DxH recombinant inbred mouse strains differing in fear recall and extinction
Q95307226Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
Q64267299Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis
Q52559088Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome.
Q47908228Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience.
Q40266004Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology.
Q35040094Evidence that transition from health to psychotic disorder can be traced to semi-ubiquitous environmental effects operating against background genetic risk
Q38254790Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis
Q36071272Exposure to environmental factors increases connectivity between symptom domains in the psychopathology network
Q90392421Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes
Q30881360Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.
Q39905473Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
Q38879526Genetic Overlap Between Schizophrenia and Developmental Psychopathology: Longitudinal and Multivariate Polygenic Risk Prediction of Common Psychiatric Traits During Development
Q39432209Guidelines for the Pharmacotherapy of Schizophrenia in Adults
Q35759415Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication
Q36542913INCREASED INTERNET USE AND POORER ABILITY TO MANAGE EMOTIONS IN YOUTH AT HIGH-RISK FOR PSYCHOSIS
Q48201789Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility study
Q47708592Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study
Q42376197Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms
Q42315776Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms.
Q50460088Implication of reward alterations in the expression of negative symptoms in 22q11.2 deletion syndrome: a behavioural and DTI study.
Q31122156Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation
Q41658737Improving outcomes of first-episode psychosis: an overview
Q47222599Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort.
Q38758518Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).
Q57031589Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation
Q57145351Interpersonal processes in paranoia: a systematic review
Q50596157Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis.
Q47620192Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence
Q97517737Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study
Q35739838Intrinsic Functional Connectivity in Salience and Default Mode Networks and Aberrant Social Processes in Youth at Ultra-High Risk for Psychosis
Q47596285Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups
Q36148454Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study
Q89086766Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk
Q53424592Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Q47677681Measuring mental health in the clinical setting: what is important to service users? The Mini-Service user Recovery Evaluation scale (Mini-SeRvE).
Q47563530Mediators Linking Childhood Adversities and Trauma to Suicidality in Individuals at Risk for Psychosis.
Q40333875Modeling the Interplay Between Psychological Processes and Adverse, Stressful Contexts and Experiences in Pathways to Psychosis: An Experience Sampling Study
Q36111457Neural correlates of aberrant emotional salience predict psychotic symptoms and global functioning in high-risk and first-episode psychosis
Q35140476Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up
Q35928509Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis
Q91705551Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature
Q47276081Non-Suicidal Self-Injury in Pediatric Bipolar Disorder: Clinical Correlates and Impact on Psychosocial Treatment Outcomes.
Q38191255Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function
Q99402426Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis
Q60625022Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
Q47243786Peer status in relation to psychotic experiences and psychosocial problems in adolescents: a longitudinal school-based study
Q47651190Perceptual abnormalities in an ultra-high risk for psychosis population relationship to trauma and co-morbid disorder
Q37258886Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population
Q47411862Physical health promotion for young people at ultra-high risk for psychosis: An application of the COM-B model and behaviour-change wheel.
Q39824871Polish individuals with an at-risk mental state: demographic and clinical characteristics
Q48016695Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity
Q56876569Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression
Q91432385Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator
Q64990683Predictors of Lifetime Suicide Attempts in Individuals With Attenuated Psychosis Syndrome.
Q41321845Prisoners at ultra-high-risk for psychosis: a cross-sectional study.
Q35639344Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study
Q100454919Progression from being at-risk to psychosis: next steps
Q39177987Progression from unipolar depression to schizophrenia
Q37098386Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis
Q64282103Psychological interventions for people with psychotic experiences: protocol for a systematic review and meta-analysis
Q39153390Psychotic experiences and psychological distress predict contemporaneous and future non-suicidal self-injury and suicide attempts in a sample of Australian school-based adolescents
Q90218602Rationale, Methods, Feasibility, and Preliminary Outcomes of a Transdiagnostic Prevention Program for At-Risk College Students
Q91218920Reasoning bias, working memory performance and a transdiagnostic phenotype of affective disturbances and psychotic experiences in the general population
Q37589487Reconsidering Clinical Staging Model: A Case of Genetic High Risk for Schizophrenia
Q47563160Relationship between metacognitive beliefs and psychosocial performance in at-risk states of psychosis and patients with first psychotic episodes
Q37696740Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis
Q35624912Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders
Q88407120Resting state connectivity dynamics in individuals at risk for psychosis
Q41656821Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.
Q44666926Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia
Q37183961Shared Etiology of Psychotic Experiences and Depressive Symptoms in Adolescence: A Longitudinal Twin Study.
Q64257794Social Mindfulness and Psychosis: Neural Response to Socially Mindful Behavior in First-Episode Psychosis and Patients at Clinical High-Risk
Q57170494Social reward processing: A biomarker for predicting psychosis risk?
Q35950862Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis
Q36817265Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study
Q92202540Stress perception following childhood adversity: Unique associations with adversity type and sex
Q39310306Stress sensitivity as a putative mechanism linking childhood trauma and psychopathology in youth's daily life.
Q94561042Study Protocol for a Prospective Longitudinal Cohort Study to Identify Proteomic Predictors of Pluripotent Risk for Mental Illness: The Seoul Pluripotent Risk for Mental Illness Study
Q30491259Subclinical psychotic experiences and subsequent contact with mental health services.
Q41590809Suicidality, self-harm and psychotic-like symptoms in a general adolescent psychiatric sample
Q36223560The Reliability and Validity of Liu´s Self-Report Questionnaire for Screening Putative Pre-Psychotic States (BQSPS) in Adolescents
Q33581212The Role of Trauma and Stressful Life Events among Individuals at Clinical High Risk for Psychosis: A Review
Q47782985The association between sleep dysfunction and psychosis-like experiences among college students.
Q47585327The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group
Q90133833The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness
Q92202461The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling
Q38232366The neurobiology and treatment of first-episode schizophrenia
Q47832927The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis
Q37182953The role of rumination in illness trajectories in youth: linking trans-diagnostic processes with clinical staging models.
Q39760221Theory of Mind Impairments in Youth at Clinical High Risk of Psychosis
Q36995932Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS
Q35096541Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project
Q91214238TwinssCan - Gene-Environment Interaction in Psychotic and Depressive Intermediate Phenotypes: Risk and Protective Factors in a General Population Twin Sample
Q89061238Using Online Screening in the General Population to Detect Participants at Clinical High-Risk for Psychosis
Q90570746Validation of the Korean Version of the 15-Item Community Assessment of Psychic Experiences in a College Population
Q92895356What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors
Q52660954Youth Mental Health Should Be a Top Priority for Health Care in Canada.

Search more.